Biorestorative Therapies Inc (BRTX) Gross Profit Margin starting from the first quarter 2026 to first quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Biorestorative Therapies Inc   (NASDAQ: BRTX)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Biorestorative Therapies Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BRTX Gross Profit Margin (Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Mar 31 2025)
Q1
Y / Y Revenue Change 14.6 %
Seq. Revenue Change 46.17 %
Revenue In Millions $0.03
Gross Profit Margin 55.1 %
Gross Profit Margin Total Ranking # 1537
Gross Profit In Millions $0.02
Y / Y Gross Profit Change -28.55 %
Seq. Gross Profit Change -12.13 %


Commenting First Quarter 2026 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 55.1 % due to increase in Cost of Sales and despite Revenue increase of 46.17 % to $0 millions.
Company's Gross Profit Margin in I. Quarter, was lower than company average.


Observing first quarter 2026 results within Healthcare Facilities industry 14 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 334 to 1537.
Learn about Gross Margin
BRTX's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Healthcare Facilities Industry # 15
Healthcare Sector # 281
Overall # 1526

Gross Profit Margin Statistics
High Average Low
99.89 % 78.56 % 10.42 %
(Mar 31 2016)   (Sep 30 2025)


BRTX Gross Income Trends • More of BRTX's Profitabilty Ratios • BRTX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BRTX's Cumulative Gross Profit Margin
Healthcare Facilities Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BRTX's Gross Profit Margin Profitability versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BRTX's Competitors
Gross Profit Margin Profit Margin for Biorestorative Therapies Inc 's Suppliers
Gross Profit Margin Profit Margin for BRTX's Customers

You may also want to know
BRTX's Annual Growth Rates BRTX's Profitability Ratios BRTX's Asset Turnover Ratio BRTX's Dividend Growth
BRTX's Roe BRTX's Valuation Ratios BRTX's Financial Strength Ratios BRTX's Gross Profit Growth
BRTX's Roa BRTX's Inventory Turnover Ratio BRTX's Growth Rates BRTX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Healthcare Facilities Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Tenet Healthcare Corp  97.35 %$ 5,226.000  Millions$ 5,368.000  Millions
Brookdale Senior Living Inc   95.16 %$ 727.829  Millions$ 764.856  Millions
Lifemd Inc   89.85 %$ 44.237  Millions$ 49.237  Millions
Biocorrx Inc   88.26 %$ 0.189  Millions$ 0.215  Millions
Community Health Systems Inc   85.13 %$ 2,524.000  Millions$ 2,965.000  Millions
Cryo cell International Inc   78.44 %$ 6.027  Millions$ 7.683  Millions
Sbc Medical Group Holdings Incorporated  71.66 %$ 30.347  Millions$ 42.347  Millions
Teladoc Health Inc   67.82 %$ 416.319  Millions$ 613.845  Millions
Hims and Hers Health Inc   65.28 %$ 396.787  Millions$ 607.787  Millions
Brightspring Health Services Inc   64.97 %$ 482.222  Millions$ 742.222  Millions
The Oncology Institute Inc   63.79 %$ 94.058  Millions$ 147.441  Millions
Airsculpt Technologies Inc   60.43 %$ 23.801  Millions$ 39.389  Millions
Cardiff Lexington Corporation  59.31 %$ 1.318  Millions$ 2.222  Millions
Viemed Healthcare Inc   56.79 %$ 42.827  Millions$ 75.414  Millions
Biorestorative Therapies Inc   55.10 %$ 0.016  Millions$ 0.029  Millions
Sotera Health Company  52.70 %$ 147.069  Millions$ 279.069  Millions
Enhabit Inc   49.32 %$ 130.600  Millions$ 264.800  Millions
Mangoceuticals Inc   42.73 %$ 0.029  Millions$ 0.068  Millions
Chemed Corporation  32.82 %$ 215.764  Millions$ 657.513  Millions
Addus Homecare Corp  31.93 %$ 115.873  Millions$ 362.873  Millions
Aveanna Healthcare Holdings Inc   31.71 %$ 205.428  Millions$ 647.915  Millions
Concentra Group Holdings Parent Inc   29.93 %$ 170.469  Millions$ 569.555  Millions
Marpai Inc  27.12 %$ 1.205  Millions$ 4.444  Millions
Progyny Inc   25.32 %$ 83.071  Millions$ 328.071  Millions
Pacs Group Inc   24.35 %$ 345.958  Millions$ 1,420.494  Millions
Ensign Group Inc  21.12 %$ 293.370  Millions$ 1,389.196  Millions
Option Care Health Inc   19.40 %$ 262.014  Millions$ 1,350.654  Millions
Healthcare Services Group Inc   16.39 %$ 75.834  Millions$ 462.766  Millions
Adapthealth Corp   13.60 %$ 111.501  Millions$ 819.799  Millions
Select Medical Holdings Corp  12.34 %$ 175.468  Millions$ 1,421.476  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.